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Psoriasis is a chronic, persistent, life-long 
inflammatory disease.1 Psoriasis is an 
inflammatory disease presenting with red 
scales on the skin, most commonly at the 
elbows and knees. At the moment there is 
no complete cure for this disease but there 
are a wide range of therapies which can 
control it, and the patients can live a normal 
life.2 However  this brings on the patients 
an economic burden, which increases in 
proportion with the severity of the disease.3
Management
This disease can be managed efficiently 
by a large variety of therapies. Studies 
have shown that there is a low adherence 
(around 40%) to treatment in this 
subpopulation. Factors such as efficacy 
and duration of the treatment are important 
in the adherence to treatment.4 Localised 
psoriasis at the knees and elbows are 
usually treated with topical corticosteroids 
or Vitamin D analogues. On the other hand, 
more severe and extensive psoriasis can 
be better managed by systemic therapies 
such as methotrexate or acritretin and/or 
phototherapy.5
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complications
Psoriasis may result in psychosocial 
disability that is similar to that of 
patients suffering from  diabetes, 
depression and other chronic 
illness. Patients may also have a 
low self-esteem due to shame and 
embarrassment about their body 
image and stigmatization.4 In a survey 
carried out by Ramsay and O’Reagan6 
about the social and psychological 
effects of psoriasis, it was found 
out that most of the patients with 
psoriasis avoid social activities such 
as swimming and sports. Half of the 
patients participating in this survey 
felt that their sexual relationships 
where inhibited by this condition and 
11% said they were not going to have 
any children to avoid the risk of their 
offspring developing this disorder as 
well.  
conclusion
Due to the complexity of this skin 
condition and the several effects it 
has on the patient’s health, psoriasis 
patients should receive regular 
health assessments to increase the 
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awareness of the condition which would 
in turn lead to an improvement in their 
own overall health. This is important as 
patients with psoriasis have an increased 
risk of death at a younger age.7
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